Skip to main content

Table 11 Generic brands pricing strategies in comparison to OB in Qatar

From: Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon

Qatar

First generic

-35% of the OB price

Second until fourth chronologically registered generics

-10% from the last registered generic

Fifth generic onward

Same price as the fourth registered generic in the market

Locally manufactured under licensed or locally packaged generics

Same pricing mechanism as imported generics